Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
01/2009
01/15/2009WO2009009173A2 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases
01/15/2009WO2009008882A1 Compositions and methods for altering stool quality in an animal
01/15/2009WO2009008803A1 Inhibition of gastroduodenal diseases in humans by common edible plants
01/15/2009WO2009008719A2 Treatment and prevention of inflammatory diseases and autoimmune diseases
01/15/2009WO2009008539A1 Carbostyril derivatives including cilostazol for treating fatty liver
01/15/2009WO2009008120A1 Agent and method for stabilizing membrane protein
01/15/2009WO2009007532A2 Use of a haemoglobin for the preparation of dressings and resulting dressings
01/15/2009WO2009006699A1 Biofilm treatment
01/15/2009WO2008144473A3 Chimeric pufa polyketide synthase systems and uses thereof
01/15/2009WO2008136865A9 (s)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs
01/15/2009WO2008095912A3 Enantiopure pharmacologically active tricyclic benzimidazoles
01/15/2009WO2008077614A3 Use of a composition made of mineral nutrients and optionally acetogenic and/or butyrogenic bacteria in order to avoid or reduce the formation of gas in the large intestine of a mammal and the resulting abdominal problems
01/15/2009WO2008077170A3 Benzothioamides, and use thereof for relaxing smooth muscles
01/15/2009WO2008064756A3 Use of substances reducing cellular glutathione content for producing a medicament for treating t-cell mediated autoimmune diseases
01/15/2009US20090018331 Condensed imidazole derivatives
01/15/2009US20090018209 Curcumin and curcuminoid inhibition of angiogenesis
01/15/2009US20090018183 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
01/15/2009US20090018179 Novel crystals and process of making 5-(-methyl)-2-methoxy-benzoic acid
01/15/2009US20090018161 Method for promoting gastrointestinal function and method for screening for promoter of gastrointestinal function
01/15/2009US20090018150 5-Ht2b Receptor Antagonists
01/15/2009US20090018135 Methods of treating bowel disorders
01/15/2009US20090018133 Novel Adamantane Derivatives
01/15/2009US20090018116 Therapeutic Compounds
01/15/2009US20090018106 Intravenous formulations of pyridoxal 5'- phosphate and method of preparation
01/15/2009US20090018077 Fibroblast Growth Factor-Like Polypeptides
01/15/2009US20090018076 Fibroblast Growth Factor-Like Polypeptides
01/15/2009US20090018068 G-protein coupled receptors
01/15/2009US20090018063 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis
01/15/2009US20090017117 Pellet formulation for the treatment of the intestinal tract
01/15/2009US20090017114 Tranexamic acid formulations with reduced adverse effects
01/15/2009US20090017100 Pharmaceutical composition, food or drink, or feed for intestinal disease
01/15/2009US20090017048 Novel Brachyspira hyodysenteriae vaccine
01/15/2009US20090017045 relate to various cell proliferative disorders, especially those involving muscle, nerve, and adipose tissue
01/15/2009US20090017037 Human TIMP-1 Antibodies
01/15/2009US20090017036 Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
01/15/2009US20090017034 inhibits thymic stromal lymphopoietin TSLP)-mediated lymphocyte stimulation; using these polypeptides as molecular weight markers that allow the estimation of the molecular weight of a protein or a fragmented protein
01/15/2009US20090017028 Antigen binding fragments (fab fragments) binds to a plurality of beta-chemokines; glomerulonephritis, scleroderrna, cirrhosis, multiple sclerosis, lupus nephritis, atherosclerosis, inflammatory bowel disease or rheumatoid arthritis; antiinflammatory agents
01/15/2009US20090017020 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders
01/15/2009US20090017014 Compositions and methods for the treatment of immune related diseases
01/15/2009US20090017003 Thiosulfonate anti-inflammatory agents
01/15/2009DE102007043187A1 Inhibierung des Hepatitis B-Virus durch Cyclohexenonverbindungen aus Antrodia camphorata Inhibition of hepatitis B virus by cyclohexenone from Antrodia camphorata
01/15/2009CA2728568A1 Composition and packaging method for animal dental care
01/15/2009CA2695126A1 Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy- benzoic acid
01/15/2009CA2693695A1 Biofilm treatment
01/15/2009CA2691632A1 Carbostyril derivatives including cilostazol for treating fatty liver
01/15/2009CA2691068A1 Use of a haemoglobin for the preparation of dressings and resulting dressings
01/15/2009CA2682096A1 Klotho beta
01/14/2009EP2014764A1 Method of producing dry yeast containing s-adenosyl-l-methionine and composition for oral intake
01/14/2009EP2014677A1 A-33 related antigens and their pharmacological uses
01/14/2009EP2014652A1 Activating agent for peroxisome proliferator activated receptor
01/14/2009EP2014298A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
01/14/2009EP2014290A2 Use of tenatoprazole for the treatment of gastroesophageal reflux disease
01/14/2009EP2014283A1 Anti-inflammatory agent and cancer-preventive agent comprising canolol or prodrug thereof and pharmaceutical, cosmetic and food comprising the same
01/14/2009EP2014181A2 Compositions based on prebiotic and immunogenic ingredients for the prevention and treatment of gastroenteric disorders caused by dysbiosis and/or alterations of the normal intestinal flora
01/14/2009EP2014180A1 Composition useful for the reduction of the cardivascular risk and foods that contain it
01/14/2009EP2014178A1 Temporally meal menu for infants
01/14/2009EP2013198A2 Solid-state form of amg 706 and pharmaceutical compositions thereof
01/14/2009EP2013178A1 Piperazine derivatives as growth hormone secretagogue (ghs) receptor agonists
01/14/2009EP2013175A1 p38 MAP KINASE INHIBITORS
01/14/2009EP2012807A1 Pharmaceutical composition of enterosorbent and prebiotics, dosage forms, and the method for prevention and treatment of gastrointestinal disorders
01/14/2009EP2012790A2 Treatment of inflammatory and ulcerative diseases of the bowel with opioid antagonists
01/14/2009EP2012769A1 Potassium channel activators for the prevention and treatment of dystonia and dystonia-like symptoms
01/14/2009EP2012768A1 Oral patch with salt of glycyrrhetinic acid water soluble at human mouth temperatures
01/14/2009EP2012754A1 Oral rapid release pharmaceutical formulation for pyridylmethylsulfinyl-benzimidazoles
01/14/2009EP1588707B1 Stable solid medicinal composition for oral administration of ramosetron
01/14/2009EP1430025B1 Methods and compositions for treating or preventing bacterial infection
01/14/2009EP1429769B1 New formulations and use thereof
01/14/2009EP1395567B1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
01/14/2009EP1345899B1 N-substituted amides as NK1 receptor antagonists
01/14/2009EP1317443B1 Chemokine receptor binding heterocyclic compounds
01/14/2009EP1300396B1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
01/14/2009EP1297142B1 Dual specificity antibodies and methods of making and using
01/14/2009EP1131337B1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors
01/14/2009EP1115877B1 Polynucleotide constructs and uses thereof
01/14/2009EP1107775B2 Composition containing pyrrolizidine-alkaloid-free petasites
01/14/2009EP0841937B2 Use of betaglycan to reduce scarring
01/14/2009CN101346366A Benzochromene derivatives
01/14/2009CN101343606A Life prolonging wine and preparation
01/14/2009CN101343604A Health care soak wine and preparation method thereof
01/14/2009CN101343324A Method for the inhibition of human TNF alpha activity
01/14/2009CN101343318A Peptide-polymer conjugates
01/14/2009CN101343307A Preparation method for carbenoxolone sodium
01/14/2009CN101343290A Preparation method for adefovir dipivoxil ester waterless crystallization article, prepared adefovir dipivoxil ester waterless crystallization article and uses thereof
01/14/2009CN101343267A Preparation method for optical pure Pantoprazole
01/14/2009CN101343266A Preparation method for optical pure rebeprazole
01/14/2009CN101343225A Preparation method for high-purity di-coffee mesitoyl quinine acid compounds
01/14/2009CN101343219A Synthesis of Teprenone
01/14/2009CN101343078A Method of preparing aluminum magnesium carbonate
01/14/2009CN101342361A Chinese medicinal herb formulation for preventing children's viral enteritis
01/14/2009CN101342350A Medicament for treating lithiasis
01/14/2009CN101342348A Traditional Chinese medicine for treating pancreatitis
01/14/2009CN101342347A Ulcer powder for treating gastropathy
01/14/2009CN101342343A Medicament composition for treating anemia
01/14/2009CN101342341A Chinese medicinal composition for treating diarrhea and preparation method thereof
01/14/2009CN101342340A Traditional Chinese medicine for treating abdominal distention and preparation thereof
01/14/2009CN101342339A Method for preparation of í«cure of gastric ulcer in 10 daysí»
01/14/2009CN101342338A Medicament for treating hepatopathy
01/14/2009CN101342332A Yellow mulberry glossy ganoderma polyoses liquid and preparation method thereof
01/14/2009CN101342329A Medicament composition for treating dyspepsia
01/14/2009CN101342293A Traditional Chinese medicine preparation for strengthening waist and nourishing kidney